BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 34590460)

  • 21. Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics.
    Jia T; Lv Q; Zhang B; Yu C; Sang S; Deng S
    BMC Med Imaging; 2023 Jul; 23(1):93. PubMed ID: 37460990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [
    Antunovic L; Gallivanone F; Sollini M; Sagona A; Invento A; Manfrinato G; Kirienko M; Tinterri C; Chiti A; Castiglioni I
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1945-1954. PubMed ID: 28711994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T
    PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of pre-treatment 18 F-fluorodeoxyglucose PET radiomic analysis in assessing nodal involvement in cervical cancer.
    Chan KC; Perucho JAU; Subramaniam RM; Lee EYP
    Nucl Med Commun; 2023 May; 44(5):375-380. PubMed ID: 36826394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Texture analysis of high-resolution dedicated breast
    Moscoso A; Ruibal Á; Domínguez-Prado I; Fernández-Ferreiro A; Herranz M; Albaina L; Argibay S; Silva-Rodríguez J; Pardo-Montero J; Aguiar P
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):196-206. PubMed ID: 28936601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of
    Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-[
    Xu L; Huang G; Wang Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1729-1740. PubMed ID: 38150017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Value of
    Song BI; Kim HW; Won KS
    Ann Surg Oncol; 2017 Aug; 24(8):2174-2181. PubMed ID: 28432480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of
    Grut H; Dueland S; Line PD; Revheim ME
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):218-225. PubMed ID: 29026950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline
    Garcia-Vicente AM; Pérez-Beteta J; Amo-Salas M; Molina D; Jimenez-Londoño GA; Soriano-Castrejón AM; Pena Pardo FJ; Martínez-González A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions.
    Zhang R; Zhu L; Cai Z; Jiang W; Li J; Yang C; Yu C; Jiang B; Wang W; Xu W; Chai X; Zhang X; Tang Y
    Eur J Radiol; 2019 Dec; 121():108735. PubMed ID: 31733432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete Metabolic Response on Interim
    Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
    Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlations of
    Wang JL; Shi AQ; Fan CC; Wang YZ; Guo GR; Liu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):628-635. PubMed ID: 36065696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT.
    Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
    Cancer; 2015 Nov; 121(22):3965-74. PubMed ID: 26249241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
    He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
    Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volumetric and radiomics assessment of lesions with incidental [18F]FDG uptake in the colon: a retrospective radiomics study.
    Agüloğlu N; Acar Akkaya E; Binicier ÖB
    Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):145-151. PubMed ID: 34664824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between semiquantitative PET parameters and molecular subtypes of breast invasive ductal carcinoma.
    Chiacchio S; Evangelista L; Alsharif A; Manca G; DI Martino F; Negri A; Tredici M; Cervino AR; Puccini G; Filidei E; Ghilli M; Naccarato AG; Roncella M; Volterrani D
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):101-111. PubMed ID: 26329496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.